
Clinical Pharmacology & Therapeutics - Issue - nature.com science feeds
Clinical Pharmacology & Therapeutics, the most cited journal publishing primary investigation in pharmacology and pharmacy, is the authoritative, cross-disciplinary journal in experimental and clinical medicine devoted to publishing advances in the nature, action, efficacy and evaluation of therapeutics.
In This Issue
21 Jul 2010 at 12:00am
In This Issue
Clinical Pharmacology & Therapeutics 88,
139 (August 2010). doi:10.1038/clpt.2010.145
Biostatistics and Pharmacometrics: Quantitative Sciences to Propel Drug Devel...
by B P SmithJ Vincent
21 Jul 2010 at 12:00am
Biostatistics and Pharmacometrics: Quantitative Sciences to Propel Drug Development Forward
Clinical Pharmacology & Therapeutics 88,
141 (August 2010). doi:10.1038/clpt.2010.136
Authors: B P Smith
& J Vincent
Highlights
21 Jul 2010 at 12:00am
Highlights
Clinical Pharmacology & Therapeutics 88,
146 (August 2010). doi:10.1038/clpt.2010.146
Author:
ASCPT News
21 Jul 2010 at 12:00am
ASCPT News
Clinical Pharmacology & Therapeutics 88,
148 (August 2010). doi:10.1038/clpt.2010.121
Statistical Guide for Clinical Pharmacology & Therapeutics
21 Jul 2010 at 12:00am
Statistical Guide for Clinical Pharmacology & Therapeutics
Clinical Pharmacology & Therapeutics 88,
150 (August 2010). doi:10.1038/clpt.2010.113
Author:
Regulatory Challenges, Reimbursement, and Risk?Benefit Assessment
by A Breckenridge
21 Jul 2010 at 12:00am
Regulatory Challenges, Reimbursement, and Risk–Benefit Assessment
Clinical Pharmacology & Therapeutics 88,
153 (August 2010). doi:10.1038/clpt.2010.76
Author: A Breckenridge
Systematic Reviews and Meta-Analyses in the New Age of Transparency
by P K Honig
21 Jul 2010 at 12:00am
Systematic Reviews and Meta-Analyses in the New Age of Transparency
Clinical Pharmacology & Therapeutics 88,
155 (August 2010). doi:10.1038/clpt.2010.124
Author: P K Honig
ASCPT Task Force for Advancing Pharmacometrics and Integration into Drug Deve...
by M J GoldbergerN SinghS AllerheiliganJ V S GobburuR LalondeB SmithS RyderA Yozviak
21 Jul 2010 at 12:00am
ASCPT Task Force for Advancing Pharmacometrics and Integration into Drug Development
Clinical Pharmacology & Therapeutics 88,
158 (August 2010). doi:10.1038/clpt.2010.141
Authors: M J Goldberger, N Singh, S Allerheiligan, J V S Gobburu, R Lalonde, B Smith, S Ryder
& A Yozviak
Experiences with Learning and Confirming in Drug and Biological Development
by S D Patterson
21 Jul 2010 at 12:00am
Experiences with Learning and Confirming in Drug and Biological Development
Clinical Pharmacology & Therapeutics 88,
161 (August 2010). doi:10.1038/clpt.2010.50
Author: S D Patterson
Dietary Supplements and the Risk of Wernicke's Encephalopathy
by GianPietro Sechi
21 Jul 2010 at 12:00am
Dietary Supplements and the Risk of Wernicke's Encephalopathy
Clinical Pharmacology & Therapeutics 88,
164 (August 2010). doi:10.1038/clpt.2010.63
Author: GianPietro Sechi
Response to ?Dietary Supplements and the Risk of Wernicke's Encephalopathy?
by B J Gurley
21 Jul 2010 at 12:00am
Response to “Dietary Supplements and the Risk of Wernicke's Encephalopathy”
Clinical Pharmacology & Therapeutics 88,
164 (August 2010). doi:10.1038/clpt.2010.104
Author: B J Gurley
Clinical Trial Simulation: A Review
by N HolfordS C MaB A Ploeger
21 Jul 2010 at 12:00am
Clinical Trial Simulation: A Review
Clinical Pharmacology & Therapeutics 88,
166 (August 2010). doi:10.1038/clpt.2010.114
Authors: N Holford, S C Ma
& B A Ploeger
Biological and Hemodynamic Effects of Low Doses of Fludrocortisone and Hydroc...
by B LaviolleP Le MaguetM-C VerdierC MassartE DonalF LainéA LavenuD PapeE Bellissant
21 Jul 2010 at 12:00am
Biological and Hemodynamic Effects of Low Doses of Fludrocortisone and Hydrocortisone, Alone or in Combination, in Healthy Volunteers With Hypoaldosteronism
Clinical Pharmacology & Therapeutics 88,
183 (August 2010). doi:10.1038/clpt.2010.83
Authors: B Laviolle, P Le Maguet, M-C Verdier, C Massart, E Donal, F Lainé, A Lavenu, D Pape
& E Bellissant
Genetic Variations in GRIA1 on Chromosome 5q33 Related to Asparaginase Hypers...
by S-H ChenD PeiW YangC ChengS JehaN J CoxW E EvansC-H PuiM V Relling
21 Jul 2010 at 12:00am
Genetic Variations in GRIA1 on Chromosome 5q33 Related to Asparaginase Hypersensitivity
Clinical Pharmacology & Therapeutics 88,
191 (August 2010). doi:10.1038/clpt.2010.94
Authors: S-H Chen, D Pei, W Yang, C Cheng, S Jeha, N J Cox, W E Evans, C-H Pui
& M V Relling
Pharmacokinetics, Pharmacodynamics, and Tolerability of Aleglitazar in Patien...
by P Sanwald-DucrayX Liogier D'ardhuyC JamoisL Banken
21 Jul 2010 at 12:00am
Pharmacokinetics, Pharmacodynamics, and Tolerability of Aleglitazar in Patients With Type 2 Diabetes: Results From a Randomized, Placebo-Controlled Clinical Study
Clinical Pharmacology & Therapeutics 88,
197 (August 2010). doi:10.1038/clpt.2009.259
Authors: P Sanwald-Ducray, X Liogier D'ardhuy, C Jamois
& L Banken
Presented by MedRat®